Stocktoria
Avantor, Inc. AVTR
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 2019-05-17
Avantor, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.6B | $6.8B | $7.0B | $7.5B | $7.4B |
| Gross profit | $2.1B | $2.3B | $2.4B | $2.6B | $2.5B |
| SG&A expense | $1.6B | $1.6B | $1.5B | $1.5B | $1.5B |
| Operating income | -$246.2M | $1.1B | $696.4M | $1.1B | $972.2M |
| Interest expense | — | — | $284.8M | $265.8M | $217.4M |
| Income tax | $88.9M | $142.4M | $89.4M | $164.6M | $180.4M |
| Net income | -$530.2M | $711.5M | $321.1M | $686.5M | $572.6M |
| EPS (diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| Operating cash flow | $623.8M | $840.8M | $870.0M | $843.6M | $953.6M |
| Free cash flow | $495.0M | $692.0M | $723.6M | $710.2M | $842.5M |
| Cash & equivalents | $365.4M | $261.9M | $262.9M | $372.9M | $301.7M |
| Inventory | $818.2M | $731.5M | $828.1M | $913.5M | $872.0M |
| Total assets | $11.8B | $12.1B | $13.0B | $13.5B | $13.9B |
| Total liabilities | $6.2B | $6.2B | $7.7B | $8.6B | $9.7B |
| Shareholders' equity | $5.6B | $6.0B | $5.3B | $4.9B | $4.2B |
Source: SEC EDGAR filings · CIK 0001722482 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.